학술논문
204 REFINE-Lung is a multicentre phase III study to determine the optimal frequency of pembrolizumab in advanced non-small cell lung cancer (NSCLC) utilising a novel multi-arm design
Document Type
Abstract
Author
Ghorani, Ehsan; Quartagno, Matteo; Blackhall, Fiona; O'Brien, Mary; Ottensmeier, Christian; Pizzo, Elena; Spicer, James; Gilbert, Duncan; Baker, Alex; Badman, Philip; Milner-Watts, Charlotte; D. d'Arienzo, Paolo; Dangoor, Adam; Adhikaree, Jason; Evans, Joanne; Leite, Pollyanna; Keni, Manjusha; Steele, Nicola; Gomes, Fabio; Gomez-Randulfe, Igor; Belitei, Petru; Stewart, Grant; Barrie, Colin; Geldart, Tom; Jain, Pooja; Liu, Justin KH; Zubairi, Ishtaiq; Muthukumar, Dakshinamoorthy; Gray, Lucy; Treece, Sarah; Aleksic, Aleksandar; Tsaknis, Georgios; Rathbone, Emma; Shaw, Paul; Tarver, Kathryn; Parmar, Mahesh K.B.; Seckl, Michael J.
Source
In Lung Cancer April 2024 190 Supplement 1
Subject
Language
ISSN
0169-5002